EXAS - Exact Sciences gains as TD Cowen sees 25% price hike for next-gen Cologuard
2024-06-26 15:12:30 ET
More on Exact Sciences
- Exact Sciences: Still No Reason To Own
- Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript
- Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau
- Exact Sciences patent infringement case against Geneoscopy to proceed
- Most attractive short-term overwriting stocks for June expiration - Goldman